NEW YORK (GenomeWeb News) — Rosetta Genomics began trading on the New York Stock Exchange today at $7 per share with a total of 3.75 million shares.
 
The company’s bid price opened today at $7.02 and by mid-afternoon had climbed almost 7 percent to $7.50.

 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

US Attorney General Jeff Sessions is considering using DNA tests to determine relatedness between adult and child migrants, the Daily Caller reports.

Bloomberg reports that Brainstorm Cell Therapeutics plans to offer a treatment it is developing under the "right to try" law for hundreds of thousands of dollars.

In a proof-of-concept study, researchers report being able to determine age from dried bloodstains, Discover's D-brief blog reports.

In Nature this week: expansion of disease-resistance genes among long-lived oak trees, and more.